Pacific Biosciences Of California | PACB - Cost Of Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Pacific Biosciences Of California

Pacific Biosciences Of California reported $29.14M in Cost of Sales for its fiscal quarter ending in March of 2023.


Cost Of Sales Change
Accelerate Diagnostics AXDX:US USD 1.8M 330K
Agilent A:US USD 793M 5M
Bruker BRKR:US USD 325.6M 17.2M
Danaher DHR:US USD 2.8B 633M
General Electric GE:US USD 10.95B 4.81B
Illumina ILMN:US USD 432M 21M
Myriad Genetics MYGN:US USD 59.2M 5.3M
NanoString Technologies NSTG:US USD 22.87M 1.75M
Pacific Biosciences Of California PACB:US USD 29.14M 10.63M
PerkinElmer PKI:US USD 293.5M 11.38M
Quidel QDEL:US USD 397.5M 20M
Roche Holding ROG:VX CHF 8.95B 613M
Standard Biotools Inc FLDM:US USD 25.99M 10.14M
Thermo Fisher Scientific TMO:US USD 6.44B 278M
Waters WAT:US USD 284.38M 63.81M